Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization - Total: 2023-2025

Historic Depreciation & Amortization - Total for MDxHealth (MDXH) over the last 3 years, with Sep 2025 value amounting to $957,000.

  • MDxHealth's Depreciation & Amortization - Total rose 16.57% to $957,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 1045.27%. This contributed to the annual value of $1.3 million for FY2024, which is 51.24% up from last year.
  • Per MDxHealth's latest filing, its Depreciation & Amortization - Total stood at $957,000 for Q3 2025, which was up 1.16% from $946,000 recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Depreciation & Amortization - Total peaked at $957,000 during Q3 2025, and registered a low of -$1.0 million during Q4 2023.
  • Moreover, its 3-year median value for Depreciation & Amortization - Total was $821,000 (2024), whereas its average is $348,000.
  • In the last 5 years, MDxHealth's Depreciation & Amortization - Total fell by 9.20% in 2024 and then rose by 16.57% in 2025.
  • Over the past 3 years, MDxHealth's Depreciation & Amortization - Total (MRQ) stood at -$1.0 million in 2023, then rose by 9.20% to -$928,000 in 2024, then surged by 203.12% to $957,000 in 2025.
  • Its Depreciation & Amortization - Total was $957,000 in Q3 2025, compared to $946,000 in Q2 2025 and $925,000 in Q1 2025.